Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017 (2017), Article ID 8023935, 15 pages
https://doi.org/10.1155/2017/8023935
Review Article

Treatment of the Fluoroquinolone-Associated Disability: The Pathobiochemical Implications

1Physics Faculty, Laboratory of Vision Science and Optometry, Adam Mickiewicz University in Poznań, Umultowska Street 85, 61-614 Poznań, Poland
2Nanobiomedical Center of Poznań, Umultowska Street 85, 61-614 Poznań, Poland
3Department of Biochemistry, Medical University of Lodz, Mazowiecka Street 6/8, 92-215 Łódź, Poland
4Outpatient Clinic, Polish Mother’s Memorial Hospital-Research Institute, Rzgowska Street 281/289, Łódź, Poland

Correspondence should be addressed to Aleksandra Sobolewska-Włodarczyk; lp.teno.atzcop@1akswelobosalo

Received 1 July 2017; Accepted 20 August 2017; Published 25 September 2017

Academic Editor: Jacek Kurzepa

Copyright © 2017 Krzysztof Michalak et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Krzysztof Michalak, Aleksandra Sobolewska-Włodarczyk, Marcin Włodarczyk, Justyna Sobolewska, Piotr Woźniak, and Bogusław Sobolewski, “Treatment of the Fluoroquinolone-Associated Disability: The Pathobiochemical Implications,” Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 8023935, 15 pages, 2017. doi:10.1155/2017/8023935